Research location
Strasbourg
Grand Est, France
Advertisement
Research activity in Strasbourg
Grand Est, FranceCureCurrent currently publishes aggregate city-level research activity for this location: 12 trials and 12 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Strasbourg
12 linked trials · page 1 of 1An Adaptive Program of IKT-001 in Pulmonary Arterial Hypertension (PAH)NCT07365332 · 2026-04-23 · 1 site observation
RECRUITING
Cohort Study to Refine the Positioning of Closed-loop Therapy Versus Islet Transplantation in the Management of Patients With Unstable Type 1 DiabetesNCT07006272 · 2025-06-04 · 1 site observation
RECRUITING
Combined Genome and RNA Sequencing for Genetic Diagnosis of ParkinsonismNCT06576713 · 2025-01-14 · 1 site observation
RECRUITING
Identification and Characterisation of Sleep Disorders in a Population of Patients With Non-small Cell Lung CancerNCT06495346 · 2023-12-11 · 1 site observation
COMPLETED
A Study to Compare Darolutamide Given With Androgen Deprivation Therapy (ADT) and Placebo Given With ADT in Men With Hormone Sensitive Prostate Cancer and Raise of Prostate Specific Antigen (PSA) Levels After Local TherapiesNCT05794906 · 2023-04-03 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study to Learn More About How Well Elinzanetant Works and How Safe it is Compared to Placebo for the Treatment of Hot Flashes Caused by Anti-cancer Therapy in Women With, or at High Risk for Developing Hormone-receptor Positive Breast CancerNCT05587296 · 2022-10-14 · 1 site observation
ACTIVE_NOT_RECRUITING
RADIANT: A Study of Radium-223 Dichloride (Xofigo) vs Enzalutamide or Abiraterone (ARPIs, Androgen Receptor Pathway Inhibitors) in Patients With Prostate Cancer That Has Spread to the Bones (mCRPC, Metastatic Castration-Resistant Prostate Cancer)NCT04597125 · 2020-11-09 · 1 site observation
ACTIVE_NOT_RECRUITING
Firibastat in Treatment-resistant HypertensionNCT04277884 · 2020-06-25 · 1 site observation
COMPLETED
One-year Persistence to Treatment of Participants Receiving Flixabi or Imraldi: a French Cohort StudyNCT03662919 · 2018-07-02 · 1 site observation
COMPLETED
Validation of Strasbourg Environmental Exposure Chamber ALYATEC in Cat Allergic Subjects With AsthmaNCT04678063 · 2017-04-10 · 1 site observation
COMPLETED
Validation of Strasbourg Environmental Exposure Chamber ALYATEC in Mite Allergic Subjects With AsthmaNCT04663880 · 2016-08-30 · 1 site observation
COMPLETED
Evaluation of Rapid Emergency Echography for Acute DyspnoeaNCT02531542 · 2016-02-29 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.